Other

Reclassification from AOCI, Net of Tax

West Pharmaceutical Services Reclassification from AOCI, Net of Tax decreased by 266.7% to -$500.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 66.7%, from -$300.00K to -$500.00K.

Analysis

StatementIncome Statement
SectionOther
CategoryProfitability
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ1 2026Apr 23, 2026

How to read this metric

A large reclassification indicates the realization of previously deferred gains or losses, impacting current period earnings.

Detailed definition

The amount of gains or losses previously recognized in accumulated other comprehensive income that are reclassified into...

Peer comparison

Standard accounting metric; comparable to reclassification adjustments in the statement of comprehensive income.

Metric ID: tmo_reclassification_from_aoci_net_of_tax

Historical Data

13 periods
 Q2 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q3 '25Q1 '26
Value-$2.60M-$800.00K-$200.00K-$13.40M-$400.00K-$2.20M-$3.30M-$1.00M-$400.00K-$300.00K-$300.00K$300.00K-$500.00K
QoQ Change+69.2%+75.0%<-999%+97.0%-450.0%-50.0%+69.7%+60.0%+25.0%+0.0%+200.0%-266.7%
YoY Change+92.3%+50.0%<-999%+75.4%-150.0%+81.8%+90.9%+70.0%+200.0%-66.7%
Range-$13.40M$300.00K
CAGR-42.3%
Avg YoY Growth-55.6%
Median YoY Growth+72.7%

Reclassification from AOCI, Net of Tax at Other Companies

Frequently Asked Questions

What is West Pharmaceutical Services's reclassification from aoci, net of tax?
West Pharmaceutical Services (WST) reported reclassification from aoci, net of tax of -$500.00K in Q1 2026.
How has West Pharmaceutical Services's reclassification from aoci, net of tax changed year-over-year?
West Pharmaceutical Services's reclassification from aoci, net of tax decreased by 66.7% year-over-year, from -$300.00K to -$500.00K.
What does reclassification from aoci, net of tax mean?
Gains or losses moved from equity reserves into the current period's net income.